Search Saint Luke's

“Physicians see all kinds of inequities in medical care and it’s heartbreaking. But we can take care of some of those things." —John Helzberg, MD

In 2021, Saint Luke's PATH Fund and our clinical teams helped more than 500 patients receive the rehabilitative services they needed after a hospital stay.

At Saint Luke’s, our core mission is to provide superior care—and we understand that fulfilling that mission starts with investing in new clinicians.

Dr. James O’Keefe, a co-investigator of this study, explains why GLP-1 medications may be uniquely effective in addressing addictive behaviors like recreational drug use, alcohol consumption, and food cravings.

Reconnecting with a former high school classmate turned out to be a saving grace in Lori’s life.

As we age, life brings unique joys and challenges. Group therapy offers a powerful way for older adults to find support, share experiences, and heal together.

Asian individuals experience poorer outcomes after out-of-hospital cardiac arrest in the U.S. compared with white individuals, despite similar rates of bystander CPR.

A secondary analysis of the pooled STEP-HFpEF and STEP-HFpEF DM trials showed the greatest improvements in those with the most weight loss at 52 weeks.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.